caa a22 4500 445298766 CHVBK 20180317142550.0 cr unu---uuuuu 170323e20101201xx s 000 0 eng 10.1007/s11864-010-0130-4 doi (NATIONALLICENCE)springer-10.1007/s11864-010-0130-4 Phytochemicals in the Oncology Setting [Elektronische Daten] [Catherine Ulbricht, Wendy Chao] Opinion statement: Phytochemicals—the bioactive compounds found in plants—not only hold historical significance in various medical traditions, but also form the basis of many modern-day drugs. Phytochemicals are often used for primary disease prevention or as adjuncts to conventional therapies—despite uncertain effectiveness or safety. On the other hand, phytochemicals have given rise to numerous conventional drugs, which are widely used in mainstream medicine and compose the primary therapeutic strategies for numerous conditions (including cancer). In this review, we will discuss general safety considerations for integrating phytochemicals in the oncology setting. The supportive evidence and safety concerns of popular plant-based cancer therapies will also be summarized. Finally, a brief overview of the established and emerging anticancer drugs with botanical origins will be provided. Springer Science+Business Media, LLC, 2010 Ulbricht Catherine Natural Standard Research Collaboration, One Davis Square, 02144, Somerville, MA, USA aut Chao Wendy Natural Standard Research Collaboration, One Davis Square, 02144, Somerville, MA, USA aut Current Treatment Options in Oncology Springer US; http://www.springer-ny.com 11/3-4(2010-12-01), 95-106 1527-2729 11:3-4<95 2010 11 11864 https://doi.org/10.1007/s11864-010-0130-4 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s11864-010-0130-4 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Ulbricht Catherine Natural Standard Research Collaboration, One Davis Square, 02144, Somerville, MA, USA aut NATIONALLICENCE 700 1- Chao Wendy Natural Standard Research Collaboration, One Davis Square, 02144, Somerville, MA, USA aut NATIONALLICENCE 773 0- Current Treatment Options in Oncology Springer US; http://www.springer-ny.com 11/3-4(2010-12-01), 95-106 1527-2729 11:3-4<95 2010 11 11864 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer